Comprehensive pharmacologic therapy for treatment of obesity
OwnerMartin Hinzinventor
Life of this patent
Estimating the term…
Abstract
The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for brief and long durations which may be 12 months or more. The preferred procedure involves the administration of drugs in combination which are identified as: Citalopram (Celexa) and Phentermine; Citalopram (Celexa) and Diethylpropion; Citalopram (Celexa), Phentermine, and Diethylpropion. In addition nutritional supplementation such as a multivitamin, 5-Hydroxytryptophan, vitamin B6, vitamin C, Tyrosine, Calcium, and Lysine may be used to enhance the performance of the weight loss treatment program.
Claims35
A nutritional supplement preparation for consumption by a patient comprising:
- 5-hydroxytryptophan and tyrosine;
- wherein the amount of 5-hydroxytryptophan is from about 50 mg to about 900 mg and the amount of tyrosine is from about 50 mg to about 4000 mg.
A nutritional supplement therapy system comprising:
- a nutritional supplement preparation comprising 5-hydroxytryptophan, tyrosine, and at least one cofactor or nutrient selected from the group consisting of vitamin B6, vitamin C, calcium, and Lysine;
- and
- a nutritional supplement dosing instruction indicating dosages of the nutritional supplement for consumption by a person in a single day and a maximum dosage per day.
A method of administering a nutritional supplement preparation for treating neurotransmitter deficiency in a patient, the method comprising providing for a daily consumption, simultaneously or separately, from about 190 mg to about 900 mg of 5-hydroxytryptophan and from about 50 mg to about 4000 mg of tyrosine.
A method of treating neurotransmitter deficiency in a patient, the method comprising:
- providing an effective therapeutic amount of 5-hydroxytryptophan and an effective therapeutic amount of tyrosine to control neurotransmitter deficiency;
- wherein the effective therapeutic amount of 5-hydroxytryptophan is from about 50 mg to about 900 mg and the effective therapeutic amount of tyrosine is from about 50 mg to about 4000 mg.
Dependencies are inferred from the claim text.